European Medicines Agency grants conditional marketing authorisation of Astra Zeneca COVID-19 Vaccine

This is the third COVID-19 vaccine that EMA has recommended for authorisation in people from 18 years of age. Approval was based on two studies which demonstrated a 59.5% reduction in the number of symptomatic COVID-19 cases in people given the vaccine vs controls.

SPS commentary:

This approval is supported by a number of documents including an FAQ.

Source:

European Medicines Agency

Resource links:

FAQ